You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Gammopathy of Undermined Significance

Showing 1 - 25 of 6,052
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 31, 2023

Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

Not yet recruiting
  • Monoclonal Gammopathy of Uncertain Significance
  • Zanubrutinib Oral Product
  • Utrecht, Netherlands
    University Medical Center Utrecht
Jul 6, 2023

Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM) Trial (Linvoseltamab)

Not yet recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma (SMM)
  • (no location specified)
Nov 17, 2023

Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

Recruiting
  • Monoclonal Gammopathy
  • Boston, Massachusetts
  • +1 more
Nov 16, 2022

Quality of Life in Asymptomatic Monoclonal Gammopathies

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance Trial in Washington (Daratumumab and

Not yet recruiting
  • Peripheral Neuropathy
  • Monoclonal Gammopathy of Undetermined Significance
  • Daratumumab and hyaluronidase-fihj
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Sep 14, 2023

Study in Monoclonal Gammopathy of Undetermined Significance

Not yet recruiting
  • MGUS
    • Oxford, Oxfordshire, United Kingdom
      Secure Study
    Sep 9, 2022

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae

    Recruiting
    • Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
    • Whole Foods Plant-based Diet
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Metformin XR
    • Placebo
    • Boston, Massachusetts
    • +6 more
    Oct 3, 2022

    Prostate Cancer, Multiple Myeloma, Smoldering Multiple Myeloma (SMM) Trial in Rochester (Curcumin plus Piperine)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Curcumin plus Piperine
    • Rochester, New York
      University of Rochester
    Jun 17, 2022

    Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

    Not yet recruiting
    • Immune System Diseases
    • +15 more
    • observational cohort study
    • (no location specified)
    Jul 23, 2023

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Plant based meals
    • Basking Ridge, New Jersey
    • +6 more
    Apr 11, 2022

    Multicenter Case Series

    Recruiting
    • Monoclonal Gammopathy of Renal Significance
      • San Fermo Della Battaglia, Como, Italy
      • +7 more
      Jan 23, 2023

      Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

      Not yet recruiting
      • Multiple Myeloma
      • +2 more
      • Multiple Myeloma M-Protein Analysis
      • Multiple Myeloma Knowledge Questionnaires
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Apr 26, 2023

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021

      A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

      Recruiting
      • Multiple Myeloma
      • +11 more
      • No intervention
      • Beijing, China
        Peking University First Hospital
      Apr 21, 2022

      Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

      Active, not recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Clinical follow-up 1
      • +5 more
      • Reykjavík, Iceland
        University of Iceland
      Feb 28, 2022

      MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      • +8 more
        • Boston, Massachusetts
        • +6 more
        Apr 14, 2022

        Progression to Myeloma in Asymptomatic Monoclonal Gammopathies

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance
        • Smoldering Plasma Cell Myeloma
        • Biospecimen Collection
        • Laboratory Biomarker Analysis
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 4, 2021

        Two Biologically and Clinically Distinct Entities: Progressive

        Recruiting
        • Multiple Myeloma
        • +2 more
          • Miami, Florida
            University of Miami Hospitals
          Jun 7, 2022

          Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)

          Not yet recruiting
          • Monoclonal Gammopathy
          • +2 more
          • DKK1
          • Cleveland, Ohio
          • +1 more
          Nov 29, 2021

          Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

          Recruiting
          • Gaucher Disease
          • Acid SphingoMyelinase Deficiency
            • Ponferrada, León, Spain
            • +11 more
            Aug 8, 2023

            Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Cryoglobulinemic Vasculitis Trial (Isatuximab Injection)

            Not yet recruiting
            • Multiple Myeloma
            • +2 more
            • Isatuximab Injection
            • (no location specified)
            Oct 28, 2021

            Monoclonal Gammopathies, Multiple Myeloma, M-protein Trial in Guangzhou (Observational studies, no intervention)

            Recruiting
            • Monoclonal Gammopathies
            • +2 more
            • Observational studies, no intervention
            • Guangzhou, Guangdong, China
              Zhujiang Hospital of Southern Medical University
            Jan 6, 2023